title: Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors.
abstract: The clinical presentation of hereditary hemochromatosis has changed markedly in recent years. The aim of this study was to analyze a large series of consecutive Italian patients with hemochromatosis diagnosed between 1976 and 2007 to determine whether the genetic background and the presence of acquired risk factors influenced the severity of iron overload and the natural history of the disease. A cohort of 452 Italian patients with iron overload-338 HFE-related (C282Y homozygotes or compound C82Y/H63D heterozygotes) and 114 non-HFE-related-were followed prospectively for a median of 112 months. Alcohol intake, smoking habits, and iron removed to depletion were similar in patients with and without HFE-related iron overload. Hepatitis B virus (4% and 9%; P = 0.04) and hepatitis C virus (6% and 19%; P = 0.002) infections were more frequent in patients with non-HFE-related iron overload. Seventy-three percent of patients with HFE and 61% of patients with non-HFE-related disease had no acquired risk factor. Cirrhosis was significantly more frequent in non-HFE patients independent of the presence of acquired risk factors (P = 0.02). Sex, alcohol intake, prevalence of smoking, hepatitis C virus infection, glucose, lipids, iron-related parameters, and prevalence of C282Y/H63D differed significantly over the years. At enrollment, cirrhosis was present in 145 cases and was significantly more frequent in the first decade (80%, 47%, and 13%; P = 0.001). Survival did not differ across the decades in cirrhotic patients; hepatocellular carcinoma occurred similarly in HFE and non-HFE patients.
  
  
  CONCLUSIONS
  Patients with HFE and non-HFE-related iron overload have comparable iron overload and similar clinical history. Patients who were diagnosed during the last 10 years and were not identified as cirrhotic at enrollment have less severe disease and lower prevalence of acquired risk factors, independent of genetic background.
authors.affiliation: Department of Internal Medicine, Policlinico Mangiagalli Regina Elena Hospital Foundation IRCCS, University of Milan, Italy.
authors.forename: Anna Ludovica
authors.initials: AL
authors.lastname: Fracanzani
authors.forename: Alberto
authors.initials: A
authors.lastname: Piperno
authors.forename: Luca
authors.initials: L
authors.lastname: Valenti
authors.forename: Mirella
authors.initials: M
authors.lastname: Fraquelli
authors.forename: Sabina
authors.initials: S
authors.lastname: Coletti
authors.forename: Alessandra
authors.initials: A
authors.lastname: Maraschi
authors.forename: Dario
authors.initials: D
authors.lastname: Consonni
authors.forename: Enzo
authors.initials: E
authors.lastname: Coviello
authors.forename: Dario
authors.initials: D
authors.lastname: Conte
authors.forename: Silvia
authors.initials: S
authors.lastname: Fargion
mesh_terms: D005260:Female; D006432:Hemochromatosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D006801:Humans; D019190:Iron Overload / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D007558:Italy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors